Results
189
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
189 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CWBC | US$15.48 | 2.2% | 22.3% | US$137.0m | US$18.00 | PB1.2x | n/a | 2.1% | Banks | ||
MEG | ₱2.21 | 1.4% | 9.4% | ₱72.0b | ₱2.38 | PE4x | E5.1% | 3.0% | Real Estate Management and Development | ||
DHLU | S$0.62 | -3.1% | 12.7% | S$432.7m | n/a | PB0.9x | E-10.5% | 7.9% | Real Estate | ||
VTLE | US$30.99 | 14.8% | -34.4% | US$1.1b | US$45.58 | PE4.4x | E24.5% | n/a | Energy | ||
ILPT | US$4.61 | -3.6% | 77.3% | US$304.2m | US$10.00 | PB0.5x | E5.5% | 0.9% | Real Estate | ||
CFW | CA$3.88 | 2.1% | -26.8% | CA$332.9m | CA$5.17 | PE2.5x | E-68.7% | 0% | Energy | ||
EW | ₱9.80 | 1.4% | 6.5% | ₱22.0b | ₱11.20 | PB0.3x | E10.0% | 5.5% | Banks | ||
BYIT | UK£5.10 | -2.2% | 4.1% | UK£1.2b | UK£6.14 | PE26.2x | E9.0% | 3.4% | Software | ||
FRAF | US$30.34 | -0.2% | 6.0% | US$133.8m | n/a | PB1x | n/a | 4.2% | Banks | ||
HNVR | US$18.24 | 0% | 1.5% | US$130.0m | US$19.50 | PB0.7x | E12.0% | 2.2% | Banks | ||
OPT | UK£1.40 | -6.7% | n/a | UK£124.3m | UK£2.35 | PS1.1x | S1.7% | n/a | Healthcare | ||
PMZ.UN | CA$15.81 | -2.4% | 19.0% | CA$1.5b | CA$17.90 | PB0.7x | S7.5% | 5.3% | Real Estate | ||
BTH | AU$0.18 | 12.5% | -48.6% | AU$147.9m | n/a | PS1.3x | E109.2% | n/a | Software | ||
BAJEL | ₹281.55 | 10.4% | n/a | ₹32.5b | n/a | PE282.5x | n/a | n/a | Utilities | ||
THL | NZ$1.80 | 1.1% | -50.4% | NZ$396.1m | NZ$3.23 | PE10.1x | E20.0% | 5.6% | Transportation | ||
MRL | UK£3.45 | 9.5% | -38.2% | UK£303.6m | UK£4.43 | PB0.7x | E93.7% | n/a | Commercial Services | ||
ESNT | UK£1.53 | -0.5% | -6.6% | UK£439.1m | UK£2.29 | PE731.9x | E2.2% | 2.4% | Materials | ||
GABC | US$38.51 | 0.7% | 42.7% | US$1.1b | US$43.00 | PB1.7x | E15.5% | 2.8% | Banks | ||
GNS | UK£20.60 | 2.2% | -3.6% | UK£1.4b | UK£26.16 | PE171x | E39.4% | 1.6% | Pharmaceuticals & Biotech | ||
CMCO | US$34.83 | -2.1% | -1.1% | US$1.0b | US$49.60 | PE21.9x | E29.8% | 0.8% | Capital Goods | ||
502168 | ₹210.40 | -1.4% | -3.5% | ₹9.5b | ₹267.00 | PE12.7x | E32.5% | 2.4% | Materials | ||
HPK | US$15.15 | 3.9% | 2.7% | US$1.9b | US$22.75 | PE12.6x | E17.5% | 1.1% | Energy | ||
SVIK | SEK 122.80 | -3.9% | 16.7% | SEK 1.0b | n/a | PE19.3x | E19.7% | 1.6% | Commercial Services | ||
DM0 | S$0.34 | -1.4% | 6.3% | S$185.4m | n/a | PE8x | n/a | 4.4% | Materials |